CAPR News

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Contact Levi & Korsinsky by September 28, 2026 to Join Class Action Against Capricor Therapeutics, Inc. (CAPR)

Pomerantz LLP Advises Shareholders of Class Action Involving Capricor Therapeutics, Inc. – CAPR

NASDAQ: CAPR: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Capricor Therapeutics, Inc

Pomerantz LLP Advises Shareholders of Class Action Filing Involving Capricor Therapeutics, Inc. – CAPR

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

$CAPR Shareholder Reminder: Capricor Therapeutics Investors Have Until September 28 to Act in Securities Fraud Class Action Over Clinical Data Issues

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR) - Contact Levi & Korsinsky

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR